February 14, 2012

Related Articles:
  • Spermicidal condoms
  • A new AIDS vaccine
  • Condom
  • Flu vaccines can be administered via a patch
Tweet

 HIV drugs
 Successfully completed the initial phase of clinical trials, which were carried out by Novosibirsk virology. The object of the test was a new experimental   HIV vaccine Which was developed at the Research Center of Virology and Biotechnology. This information recently shared SSC Director Alexander Sergeev.

According to the head of the center, as a result of new tests vaccine   It caused a reaction of both cellular and humoral level   immune system   human. It also is the hallmark of the new media as the western analogues, and on drugs, developed up to this point in Russia.

Moreover, Sergeyev said that was revealed not only high efficacy, but its good tolerability. He added that further continuation of the study is only possible with the consent of the Scientific Center of Expertise of Medical application that monitors clinical trials in Russia.

As previously reported, the government has allocated for the development of vaccines one billion rubles in 2007, as a result of this funding has created several products.